Donald Jensen to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Donald Jensen has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.134
-
Faldaprevir, pegylated interferon, and ribavirin for treatment-na?ve HCV genotype-1: pooled analysis of two phase 3 trials. Ann Hepatol. 2016 May-Jun; 15(3):333-49.
Score: 0.134